Cargando…

Non-transplant patients with haematologic malignancies have better survival outcome than recipients of haematopoietic stem cell transplant (HSCT) after admission to intensive care unit (ICU)

Detalles Bibliográficos
Autores principales:	Corcia Palomo, Y, Knight Asorey, T, Espigado Tocino, I, Martín Villén, L, Gutiérrez Pizarrayo, A, Garnacho Montero, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4798409/ http://dx.doi.org/10.1186/2197-425X-3-S1-A243

Ejemplares similares

Mortality of oncohematologic patients admitted to the intensive care unit (icu) who required invasive mechanical ventilation (imv). do we have to delay intubation?
por: Corcia Palomo, Y, et al.
Publicado: (2015)

How to treat VAP due to MDR pathogens in ICU patients
por: Garnacho-Montero, José, et al.
Publicado: (2014)

Emergence of non-susceptibility during persistent Pseudomonas aeruginosa bacteraemia in haematopoietic cell transplant recipients and haematological malignancy patients
por: Fontana, Lauren, et al.
Publicado: (2021)

Late ICU admission in liver transplant recipients: ten years experience
por: Atar, F, et al.
Publicado: (2015)

Outcomes of haematopoietic stem cell transplant patients admitted to the ICU
por: Bird, G, et al.
Publicado: (2011)

The clinical course of COVID-19 in hematopoietic stem cell transplantation (HSCT) recipients
por: KARATAŞ, Ayşe, et al.
Publicado: (2021)

P47 The conundrums of Macrophage activation syndrome (MAS) - when to consider a Haematopoietic Stem Cell Transplant (HSCT)
por: Gallagher, Kathy, et al.
Publicado: (2022)

Genomic prediction of relapse in recipients of allogeneic haematopoietic stem cell transplantation
por: Ritari, J., et al.
Publicado: (2018)

Outcome prediction in haematological patients requiring admission to the ICU
por: Gopal, S, et al.
Publicado: (2011)

452 Pseudo-Outbreak of Fulminant Toxoplasmosis in Hematopoietic Stem Cell Transplant [HSCT] Recipients
por: Isa, Flonza, et al.
Publicado: (2014)

Haemophagocytic lymphohistiocytosis (HLH) following allogeneic haematopoietic stem cell transplantation (HSCT)—time to reappraise with modern diagnostic and treatment strategies?
por: Sandler, Robert David, et al.
Publicado: (2019)

Haemorrhagic cystitis in haematopoietic stem cell transplantation (HSCT): a prospective observational study of incidence and management in HSCT centres within the GITMO network (Gruppo Italiano Trapianto Midollo Osseo)
por: Gargiulo, G, et al.
Publicado: (2014)

Clostridium difficile Infection in Solid Organ and Haematopoietic Stem Cell Transplant Recipients
por: Ilett, Emma Elizabeth, et al.
Publicado: (2017)

332. Phaeohyphomycosis Due to Scopulariopsis brumptii in a Hematopoietic Stem Cell Transplant (HSCT) Recipient
por: Syed, Sadia, et al.
Publicado: (2018)

Incidence and Outcomes of Cytomegalovirus (CMV) Infection among Hematopoietic Stem Cell Transplant (HSCT) Recipients
por: Furuno, Jon P, et al.
Publicado: (2017)

COVID-19 in HSCT recipients: a collaborative study of the Brazilian Society of Marrow Transplantation (SBTMO)
por: Daudt, Liane Esteves, et al.
Publicado: (2022)

Feasibility and safety of exercise training and nutritional support prior to haematopoietic stem cell transplantation in patients with haematologic malignancies
por: Rupnik, Erik, et al.
Publicado: (2020)

Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022
por: Snowden, John A., et al.
Publicado: (2022)

Gonadotropin-releasing hormone agonist for the preservation of ovarian function in survivors of haematopoietic stem cell transplantation for haematological diseases
por: Wang, Zhenhong, et al.
Publicado: (2022)

PB2459: AFTER ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION OUTCOMES OF HAEMATOLOGIC MALIGNANCIES COMPLICATED BY AUTOIMMUNE DISEASES
por: Kang, Ying, et al.
Publicado: (2023)

The impact of viral respiratory infections in the first year post-transplant period of pediatric hematopoietic stem cell transplant (HSCT) recipients
por: Piralla, Antonio, et al.
Publicado: (2016)

Human rhinovirus C in adult haematopoietic stem cell transplant recipients with respiratory illness
por: Ferguson, Patricia E., et al.
Publicado: (2013)

Human metapneumovirus infection in haematopoietic stem cell transplant recipients: a case series
por: Jethani, Jyoti, et al.
Publicado: (2021)

Oral Management of a Haematopoietic Stem Cell Transplant Recipient with Chédiak–Higashi Syndrome
por: Shimizu, Kasumi, et al.
Publicado: (2021)

Outcome of renal transplant recipients and graft survival in the ICU
por: Nicolet, L, et al.
Publicado: (2001)

Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE)
por: Saccardi, Riccardo, et al.
Publicado: (2023)

COVID‐19 outcomes in haematopoietic cell transplant recipients: A systematic review and meta‐analysis
por: Lim, Yeong Jer, et al.
Publicado: (2022)

Medication Adherence among Allogeneic Haematopoietic Stem Cell Transplant Recipients: A Systematic Review
por: Visintini, Chiara, et al.
Publicado: (2023)

Immunogenicity of Inactivated Varicella Zoster Vaccine (ZV(IN)) in Autologous Hematopoietic Stem Cell Transplant (auto-HSCT) Recipients
por: Boeckh, Michael, et al.
Publicado: (2017)

Evaluation of Cyclosporine Pharmacokinetic, Monitoring, and Dosing Parameters for GVHD Prophylaxis in Hematopoietic Stem Cell Transplant (HSCT) Recipients
por: Tafazoli, Ali, et al.
Publicado: (2019)

Standardizing haematopoietic cell transplants in China
por: Gale, Robert Peter
Publicado: (2018)

COVID-19 and HSCT (Hematopoietic stem cell transplant)
por: Strasfeld, Lynne
Publicado: (2022)

Establishing the hematopoietic stem cell transplant (HSCT) in a developing country; the journey of HSCT in Semarang, Indonesia
por: Santosa, Damai, et al.
Publicado: (2020)

Assessing the impact on intestinal microbiome and clinical outcomes of antibiotherapy optimisation strategies in haematopoietic stem cell transplant recipients: study protocol for the prospective multicentre OptimBioma study
por: Jiménez-Jorge, Silvia, et al.
Publicado: (2020)

Community Acquired Respiratory Viral Infections (CARV) in Patients with Acute Leukemia and Hematopoietic Stem Cell Transplant (HSCT) Recipients
por: Trikha, Gaurav, et al.
Publicado: (2016)

Higher recipient pre‐transplant FOXP3 mRNA expression is associated with acute leukaemia relapse after HSCT
por: Jacobsen, Niels, et al.
Publicado: (2022)

1073. SARS-CoV-2 Vaccine-Induced Immunogenicity among Hematopoietic Stem Cell Transplant Recipients (HSCT)
por: Kokogho, Afoke, et al.
Publicado: (2022)

926. Risk factors for post-letermovir cytomegalovirus (CMV) reactivation in allogeneic hematopoietic stem cell transplant (HSCT) recipients
por: Mendoza, Maria Alejandra, et al.
Publicado: (2023)

Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study
por: Sharma, Akshay, et al.
Publicado: (2021)

Complicated and persistent severe COVID-19 pneumonia in a recipient of allogeneic haematopoietic stem cell transplant
por: Lazzari, Lorenzo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_urkhfqum7ogb80p0ukurundqse